NUCANA PLC

Organization

EDINBURGH, GB

Ticker Symbols

NASDAQ:NCNA

PHARMACEUTICAL PREPARATIONS
Business Address
3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
Mailing Address
3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
State Location
X0
State of Incorporation
X0

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Formulations of phosphoramidate derivatives of nucleoside drugs
- Patent number 12,357,652
- Issue date Jul 15, 2025
- NuCana plc
- Gordon Kennovin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...
- Patent number 12,054,510
- Issue date Aug 6, 2024
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Synthesis of phosphate derivatives
- Patent number 12,054,511
- Issue date Aug 6, 2024
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in...
- Patent number 11,925,658
- Issue date Mar 12, 2024
- NuCana plc
- Christopher McGuigan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis of 3′-deoxyadenosine-5′-O-[phenyl(benzyloxy-L-alaninyl)]p...
- Patent number 11,897,913
- Issue date Feb 13, 2024
- NuCana plc
- Venkata Lakshmi Narasimha Rao Dammalapati
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulations of phosphoramidate derivatives of nucleoside drugs
- Patent number 11,786,544
- Issue date Oct 17, 2023
- NuCana plc
- Gordon Kennovin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Formulation comprising a gemcitabine-prodrug
- Patent number 11,707,477
- Issue date Jul 25, 2023
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gemcitabine prodrugs
- Patent number 11,629,164
- Issue date Apr 18, 2023
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Diastereoselective synthesis of phosphate derivatives
- Patent number 11,603,382
- Issue date Mar 14, 2023
- NuCana plc
- Mani Bushan Kotala
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in...
- Patent number 11,559,542
- Issue date Jan 24, 2023
- NuCana plc
- Christopher McGuigan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salts of diphosphate phosphoramidate of nucleosides as anticancer c...
- Patent number 11,560,400
- Issue date Jan 24, 2023
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthesis of phosphate derivatives
- Patent number 11,414,452
- Issue date Aug 16, 2022
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Floxuridine synthesis
- Patent number 11,414,451
- Issue date Aug 16, 2022
- NuCana plc
- Mani Bushan Kotala
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cancer treatments
- Patent number 11,400,107
- Issue date Aug 2, 2022
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline form of gemcitabine
- Patent number 11,377,467
- Issue date Jul 5, 2022
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...
- Patent number 11,352,387
- Issue date Jun 7, 2022
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulation comprising a gemcitabine-prodrug
- Patent number 11,040,051
- Issue date Jun 22, 2021
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Process for preparing nucleoside prodrugs
- Patent number 11,040,997
- Issue date Jun 22, 2021
- NuCana plc
- Christopher McGuigan
- B82 - NANO-TECHNOLOGY
Information Patent Grant
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in...
- Patent number 10,993,957
- Issue date May 4, 2021
- NuCana plc
- Christopher McGuigan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phosphoramidate nucleoside derivatives as anticancer agents
- Patent number 10,906,929
- Issue date Feb 2, 2021
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Formulation comprising a gemcitabine-prodrug
- Patent number 10,786,523
- Issue date Sep 29, 2020
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of separating gemcitabine-phosphate diastereoisomers
- Patent number 10,669,300
- Issue date Jun 2, 2020
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gemcitabine prodrugs
- Patent number 10,662,213
- Issue date May 26, 2020
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination therapy for cancer
- Patent number 10,660,912
- Issue date May 26, 2020
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...
- Patent number 10,570,168
- Issue date Feb 25, 2020
- NuCana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phosphoramidate compounds and methods of use
- Patent number RE47589
- Issue date Sep 3, 2019
- NuCana PLC
- Christopher McGuigan
Information Patent Grant
Formulation comprising a gemcitabine-prodrug
- Patent number 10,117,888
- Issue date Nov 6, 2018
- NuCana plc
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in...
- Patent number 10,022,390
- Issue date Jul 17, 2018
- NuCana plc
- Christopher McGuigan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
SYNTHESIS OF PHOSPHATE DERIVATIVES
- Publication number 20250171487
- Publication date May 29, 2025
- Nucana plc
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DE...
- Publication number 20250163096
- Publication date May 22, 2025
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER TREATMENT
- Publication number 20250144128
- Publication date May 8, 2025
- Nucana plc
- David James Harrison
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT REGIMENS
- Publication number 20240293439
- Publication date Sep 5, 2024
- NUCANA PLC
- Hugh Griffith
- G01 - MEASURING TESTING
Information Patent Application
FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS
- Publication number 20240082287
- Publication date Mar 14, 2024
- NUCANA PLC
- Gordon Kennovin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS
- Publication number 20230226092
- Publication date Jul 20, 2023
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CANCER TREATMENTS
- Publication number 20230218655
- Publication date Jul 13, 2023
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER C...
- Publication number 20230192750
- Publication date Jun 22, 2023
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHOSPHORAMIDATE DERIVATIVES OF 5 - FLUORO - 2' - DEOXYURIDINE FOR U...
- Publication number 20230165886
- Publication date Jun 1, 2023
- NUCANA PLC
- Christopher McGuigan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY
- Publication number 20230149436
- Publication date May 18, 2023
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHESIS OF PHOSPHATE DERIVATIVES
- Publication number 20220402962
- Publication date Dec 22, 2022
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION THERAPY FOR CANCER
- Publication number 20220323475
- Publication date Oct 13, 2022
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DE...
- Publication number 20220306675
- Publication date Sep 29, 2022
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FORMULATION COMPRISING A GEMCITABINE-PRODRUG
- Publication number 20220031727
- Publication date Feb 3, 2022
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESS FOR PREPARING NUCLEOSIDE PRODRUGS
- Publication number 20220033433
- Publication date Feb 3, 2022
- NUCANA PLC
- Christopher McGuigan (Deceased)
- B82 - NANO-TECHNOLOGY
Information Patent Application
FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS
- Publication number 20220031728
- Publication date Feb 3, 2022
- NUCANA PLC
- Gordon Kennovin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHOSPHORAMIDATE DERIVATIVES OF 5 - FLUORO - 2` - DEOXYURIDINE FOR U...
- Publication number 20220023330
- Publication date Jan 27, 2022
- NUCANA PLC
- Christopher McGuigan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALT OF TRIPHOSPHATE PHOSPHORAMIDATES OF NUCLEOTIDES AS ANTICANCER...
- Publication number 20220024963
- Publication date Jan 27, 2022
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORM OF GEMCITABINE
- Publication number 20210188893
- Publication date Jun 24, 2021
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER C...
- Publication number 20210171566
- Publication date Jun 10, 2021
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS
- Publication number 20210130387
- Publication date May 6, 2021
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS
- Publication number 20210100825
- Publication date Apr 8, 2021
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DIASTEREOSELECTIVE SYNTHESIS OF PHOSPHATE DERIVATIVES
- Publication number 20210009625
- Publication date Jan 14, 2021
- NUCANA PLC
- Mani Bushan Kotala
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FORMULATION COMPRISING A GEMCITABINE-PRODRUG
- Publication number 20200397810
- Publication date Dec 24, 2020
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Treatment Regimens
- Publication number 20200345755
- Publication date Nov 5, 2020
- NUCANA PLC
- Hugh Griffith
- G01 - MEASURING TESTING
Information Patent Application
COMBINATION THERAPY FOR CANCER
- Publication number 20200268783
- Publication date Aug 27, 2020
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FLOXURIDINE SYNTHESIS
- Publication number 20200262859
- Publication date Aug 20, 2020
- NuCana plc
- Mani B. Kotala
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GEMCITABINE PRODRUGS
- Publication number 20200262861
- Publication date Aug 20, 2020
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy
- Publication number 20200197430
- Publication date Jun 25, 2020
- NUCANA PLC
- Hugh Griffith
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DE...
- Publication number 20200181189
- Publication date Jun 11, 2020
- NUCANA PLC
- Hugh Griffith
- C07 - ORGANIC CHEMISTRY

Trademarklast 30 trademarks

Information Trademark
79232789 - NUTIDE
- Serial number 79232789
- Registration number 5736174
- Filing date Feb 22, 2018
- NuCana plc
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
78928727 - NUCANA
- Serial number 78928727
- Registration number 3373049
- Filing date Jul 13, 2006
- NuCana Ltd
- 5 - Pharmaceutical and veterinary preparations

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Formulations of phosphoramidate derivatives of nucleoside drugs

2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...

Synthesis of phosphate derivatives

Phosphoramidate derivatives of 5-fluoro-2′—deoxyuridine for use in...

Synthesis of 3′-deoxyadenosine-5′-O-[phenyl(benzyloxy-L-alaninyl)]p...

Formulations of phosphoramidate derivatives of nucleoside drugs

Formulation comprising a gemcitabine-prodrug

Gemcitabine prodrugs

Diastereoselective synthesis of phosphate derivatives

Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in...

Salts of diphosphate phosphoramidate of nucleosides as anticancer c...

Synthesis of phosphate derivatives

Floxuridine synthesis

Cancer treatments

Crystalline form of gemcitabine

2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...

Formulation comprising a gemcitabine-prodrug

Process for preparing nucleoside prodrugs

Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in...

Phosphoramidate nucleoside derivatives as anticancer agents

Formulation comprising a gemcitabine-prodrug

Methods of separating gemcitabine-phosphate diastereoisomers

Gemcitabine prodrugs

Combination therapy for cancer

2′ and/or 5′ amino-acid ester phosphoramidate 3′-deoxy adenosine de...

Phosphoramidate compounds and methods of use

Formulation comprising a gemcitabine-prodrug

Phosphoramidate derivatives of 5-fluoro-2′-deoxyuridine for use in...

Patents Applicationslast 30 patents

SYNTHESIS OF PHOSPHATE DERIVATIVES

2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DE...

CANCER TREATMENT

TREATMENT REGIMENS

FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS

CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS

CANCER TREATMENTS

SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER C...

PHOSPHORAMIDATE DERIVATIVES OF 5 - FLUORO - 2' - DEOXYURIDINE FOR U...

COMBINATION THERAPY

SYNTHESIS OF PHOSPHATE DERIVATIVES

COMBINATION THERAPY FOR CANCER

2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DE...

FORMULATION COMPRISING A GEMCITABINE-PRODRUG

PROCESS FOR PREPARING NUCLEOSIDE PRODRUGS

FORMULATIONS OF PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDE DRUGS

PHOSPHORAMIDATE DERIVATIVES OF 5 - FLUORO - 2` - DEOXYURIDINE FOR U...

SALT OF TRIPHOSPHATE PHOSPHORAMIDATES OF NUCLEOTIDES AS ANTICANCER...

CRYSTALLINE FORM OF GEMCITABINE

SALTS OF DIPHOSPHATE PHOSPHORAMIDATE OF NUCLEOSIDES AS ANTICANCER C...

PHOSPHORAMIDATE NUCLEOSIDE DERIVATIVES AS ANTICANCER AGENTS

CANCER TREATMENTS BASED ON GEMCITABINE PRODRUGS

DIASTEREOSELECTIVE SYNTHESIS OF PHOSPHATE DERIVATIVES

FORMULATION COMPRISING A GEMCITABINE-PRODRUG

Treatment Regimens

COMBINATION THERAPY FOR CANCER

FLOXURIDINE SYNTHESIS

GEMCITABINE PRODRUGS

Combination Therapy

2' AND/OR 5' AMINO-ACID ESTER PHOSPHORAMIDATE 3'-DEOXY ADENOSINE DE...

Trademarklast 30 trademarks

79232789 - NUTIDE

78928727 - NUCANA